Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of the American Chemical Society|April 24, 2012
Oxidation state and symmetry of magnesia-supported Pd13O(x) nanocatalysts influence activation barriers of CO oxidationMichael Moseler, Michael Walter, Bokwon Yoon, et al.
Neurourology and Urodynamics|December 27, 2024
Moving Beyond the Bladder Diary: Does New Technology Now Allow Us to Take Investigation of LUTS Into the Community? ICI-RS 2024Michael Drinnan, Paul Abrams, Salvador Arlandis, et al.
European Urology|January 23, 2025
Prevalence, Diagnosis, and Management of Stress Urinary Incontinence in Women: A Collaborative ReviewLisa Moris, John Heesakkers, Victor Nitti, et al.
BJU International|July 18, 2022
Infection after ureteroscopy for ureteric stones: analysis of 71 305 cases in the Hospital Episode Statistics databaseRajan Veeratterapillay, Paul Gravestock, Chris Harding, et al.
Neurourology and Urodynamics|December 5, 2025
Is There Adequate Evidence for Intracellular Bacteria Being a Significant Cause of rUTIs and Thereby Justifying Targeted Treatments Such as Bladder Fulguration or Intravesical Therapies? ICI-RS 2025Chris Harding, Anasofia Da Silva, Rajvinder Khasriya, et al.
Neurourology and Urodynamics|November 26, 2025
Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI-RS 2025Jalesh N Panicker, Chris Harding, Hashim Hashim, et al.
Journal of Medical Microbiology|June 3, 2025
Trimethoprim resistance in Escherichia coli exhibits an allele-specific growth advantageAlexandra Spencer, Qixiang Wong, Sophie T Lawson, et al.
BJU International|March 27, 2021
British Association of Urological Surgeons (BAUS) consensus document: Management of female voiding dysfunctionSuzanne M Biers, Chris Harding, Mo Belal, et al.
Neurourology and Urodynamics|August 23, 2018
Do we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017Jalesh N Panicker, Ralf Anding, Salvador Arlandis, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 4, 2013
Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivityRajan Veeratterapillay, Chris Harding, Luke Teo, et al.
Pageof 6